In breast cancer, lncRNA MIAT, as a ceRNA molecular sponge, competitively combines with miR‐155‐5p to achieve modulation of the expression of DUSP7 and promote the development of breast cancer (Luan et al., 2017). Here, DUSP7 is linked to breast cancer.